|
WO2020016437A1
|
|
In vitro method for the diagnosis of synucleinopathies
|
|
WO2019234196A1
|
|
In vitro method for the diagnosis or detection of non-tuberculous mycobacteria
|
|
WO2019211316A1
|
|
A non-everting anastomosis device and uses thereof
|
|
WO2019115679A1
|
|
A signature to assess prognosis and therapeutic regimen in liver cancer
|
|
EP3653646A1
|
|
Method and kit for the diagnosis and/or prognosis of inflammatory conditions
|
|
CA3079107A1
|
|
Vectors for the treatment of friedreich's ataxia
|
|
US2020063206A1
|
|
Predictive response biomarkers to corticosteroids
|
|
EP3476863A1
|
|
Anti-cd5l antibody and uses thereof
|
|
US2019262498A1
|
|
Bioadhesive platform to perform bioactive treatment
|
|
EP3442435A1
|
|
Penile surgical separator-fixator
|
|
EP3363356A1
|
|
Prognosis of endovascular treatment in acute ischemic stroke patients
|
|
EP3313310A2
|
|
Devices and kits for assisting in open surgeries
|
|
EP3294903A1
|
|
Method for in vitro diagnosis of dementia with lewy bodies using alphasynuclein gene transcripts
|
|
EP3261683A1
|
|
Topical composition for the treatment of mucosal lesions
|
|
AU2015309112A1
|
|
Neprilysin as heart failure prognostic marker
|
|
EP2776058A1
|
|
Apotransferrin for the treatment of brain stroke
|
